We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company’s Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer

Product News

oundationOne Liquid analyzes 70 genes known to drive cancer growth and reports microsatellite instability high (MSI-high) status to inform the use of precision oncology treatments, including immunotherapies, with a simple blood draw.

READ MORE

Celebrating 10 Years of Sekisui XenoTech

Product News

American innovation meets Japanese vision with a global outlook.

READ MORE

Ingenza Takes a Stake in New Spin-out Company Amprologix

Product News

Amprologix is using synthetic biology methods developed by Ingenza for industrial scale-up of epidermicin production.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE